The use of corticosteroid therapy for COVID-19 patients: an evidence-based overview

Detalhes bibliográficos
Autor(a) principal: Amaral, Ricardo Guimarães
Data de Publicação: 2022
Outros Autores: Santana, Ricardo Ruan Rocha, Barbosa, Bárbara Oliva, Araújo, Yuri Barbosa, Lauton-Santos, Sandra, Andrade, Luciana Nalone
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista Ciências em Saúde
Texto Completo: https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1264
Resumo: Since the World Health Organization declared COVID-19 as a pandemic, huge efforts to promote better treatment for the patients raised from the scientific community. One of the most effective treatment is the administration of corticosteroid in specific stages of the disease, once that severe COVID-19 pathophysiology evolves an exuberant inflammatory response, resulting in uncontrolled pulmonary inflammation and multisystem damage. However, it is still discussed whether some drugs, such as dexamethasone, are more effective than others, such as hydrocortisone and methylprednisolone. Therefore, we constructed here a comprehensive overview, based on clinical studies with detailed methodological procedures, regarding the role of corticosteroids in COVID-19 treatment. We aimed to address how the current evidence support their use in this scenario.
id RCS_04c6ba1defe509f835a33f81638bc574
oai_identifier_str oai:ojs.portalrcs.hcitajuba.org.br:article/1264
network_acronym_str RCS
network_name_str Revista Ciências em Saúde
repository_id_str
spelling The use of corticosteroid therapy for COVID-19 patients: an evidence-based overviewCorticosteroidsCOVID-19SARS-CoV-2TherapySince the World Health Organization declared COVID-19 as a pandemic, huge efforts to promote better treatment for the patients raised from the scientific community. One of the most effective treatment is the administration of corticosteroid in specific stages of the disease, once that severe COVID-19 pathophysiology evolves an exuberant inflammatory response, resulting in uncontrolled pulmonary inflammation and multisystem damage. However, it is still discussed whether some drugs, such as dexamethasone, are more effective than others, such as hydrocortisone and methylprednisolone. Therefore, we constructed here a comprehensive overview, based on clinical studies with detailed methodological procedures, regarding the role of corticosteroids in COVID-19 treatment. We aimed to address how the current evidence support their use in this scenario.AISI/HCI2022-08-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer reviewedAvaliado pelos paresinfo:eu-repo/semantics/otherapplication/pdfhttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/126410.21876/rcshci.v12i3.1264Revista Ciências em Saúde; v. 12 n. 3 (2022): Julho a Setembro de 2022; 4-11Health Sciences Journal; Vol 12 No 3 (2022): July to September 2022; 4-112236-378510.21876/rcshci.v12i3reponame:Revista Ciências em Saúdeinstname:Hospital de Clínicas de Itajubáinstacron:HCIenghttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1264/818Copyright (c) 2022 Revista Ciências em Saúdehttps://creativecommons.org/licenses/by-nc-sa/4.0info:eu-repo/semantics/openAccessAmaral, Ricardo GuimarãesSantana, Ricardo Ruan RochaBarbosa, Bárbara OlivaAraújo, Yuri BarbosaLauton-Santos, SandraAndrade, Luciana Nalone2022-09-16T14:39:39Zoai:ojs.portalrcs.hcitajuba.org.br:article/1264Revistahttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zeroPUBhttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/oaircs@hcitajuba.org.br||rcsfmit@medicinaitajuba.com.br2236-37852236-3785opendoar:2022-09-16T14:39:39Revista Ciências em Saúde - Hospital de Clínicas de Itajubáfalse
dc.title.none.fl_str_mv The use of corticosteroid therapy for COVID-19 patients: an evidence-based overview
title The use of corticosteroid therapy for COVID-19 patients: an evidence-based overview
spellingShingle The use of corticosteroid therapy for COVID-19 patients: an evidence-based overview
Amaral, Ricardo Guimarães
Corticosteroids
COVID-19
SARS-CoV-2
Therapy
title_short The use of corticosteroid therapy for COVID-19 patients: an evidence-based overview
title_full The use of corticosteroid therapy for COVID-19 patients: an evidence-based overview
title_fullStr The use of corticosteroid therapy for COVID-19 patients: an evidence-based overview
title_full_unstemmed The use of corticosteroid therapy for COVID-19 patients: an evidence-based overview
title_sort The use of corticosteroid therapy for COVID-19 patients: an evidence-based overview
author Amaral, Ricardo Guimarães
author_facet Amaral, Ricardo Guimarães
Santana, Ricardo Ruan Rocha
Barbosa, Bárbara Oliva
Araújo, Yuri Barbosa
Lauton-Santos, Sandra
Andrade, Luciana Nalone
author_role author
author2 Santana, Ricardo Ruan Rocha
Barbosa, Bárbara Oliva
Araújo, Yuri Barbosa
Lauton-Santos, Sandra
Andrade, Luciana Nalone
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Amaral, Ricardo Guimarães
Santana, Ricardo Ruan Rocha
Barbosa, Bárbara Oliva
Araújo, Yuri Barbosa
Lauton-Santos, Sandra
Andrade, Luciana Nalone
dc.subject.por.fl_str_mv Corticosteroids
COVID-19
SARS-CoV-2
Therapy
topic Corticosteroids
COVID-19
SARS-CoV-2
Therapy
description Since the World Health Organization declared COVID-19 as a pandemic, huge efforts to promote better treatment for the patients raised from the scientific community. One of the most effective treatment is the administration of corticosteroid in specific stages of the disease, once that severe COVID-19 pathophysiology evolves an exuberant inflammatory response, resulting in uncontrolled pulmonary inflammation and multisystem damage. However, it is still discussed whether some drugs, such as dexamethasone, are more effective than others, such as hydrocortisone and methylprednisolone. Therefore, we constructed here a comprehensive overview, based on clinical studies with detailed methodological procedures, regarding the role of corticosteroids in COVID-19 treatment. We aimed to address how the current evidence support their use in this scenario.
publishDate 2022
dc.date.none.fl_str_mv 2022-08-29
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Peer reviewed
Avaliado pelos pares
info:eu-repo/semantics/other
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1264
10.21876/rcshci.v12i3.1264
url https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1264
identifier_str_mv 10.21876/rcshci.v12i3.1264
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1264/818
dc.rights.driver.fl_str_mv Copyright (c) 2022 Revista Ciências em Saúde
https://creativecommons.org/licenses/by-nc-sa/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2022 Revista Ciências em Saúde
https://creativecommons.org/licenses/by-nc-sa/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv AISI/HCI
publisher.none.fl_str_mv AISI/HCI
dc.source.none.fl_str_mv Revista Ciências em Saúde; v. 12 n. 3 (2022): Julho a Setembro de 2022; 4-11
Health Sciences Journal; Vol 12 No 3 (2022): July to September 2022; 4-11
2236-3785
10.21876/rcshci.v12i3
reponame:Revista Ciências em Saúde
instname:Hospital de Clínicas de Itajubá
instacron:HCI
instname_str Hospital de Clínicas de Itajubá
instacron_str HCI
institution HCI
reponame_str Revista Ciências em Saúde
collection Revista Ciências em Saúde
repository.name.fl_str_mv Revista Ciências em Saúde - Hospital de Clínicas de Itajubá
repository.mail.fl_str_mv rcs@hcitajuba.org.br||rcsfmit@medicinaitajuba.com.br
_version_ 1797068963315712000

Registros relacionados